Generic rare disease approvals fell significantly during the early pandemic

The number of generic rare disease approvals in mature markets declined by 20% in 2020 compared with 2019 due to the Covid-19 pandemic.

Related Keywords

Japan , ,Laboratory Equipment ,Validation Services ,National Institutes Of Health ,Drug Administration ,Rare Diseases Information Centre ,National Institutes ,Eiger Biopharmaceuticals ,Pharmaceutical Technology ,Shipping Temperature ,Design Build ,Research Organisation ,Early Development ,